NFE2L2 and neoplasm: Indeed, DMF is in clinical trial for the treatment of different cancer types, considering its link with a wide range of pathways and kinases involved in tumor progression, such as the KEAP1-NRF2 pathway, NF-κB, ERK, and MAPKs [32].